Bundamedik Tbk vs Saraswanti Indoland Development Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Saraswanti Indoland Development Tbk. trades at Rp93 (market cap 490.04B, 960.5K 24h volume). The key difference: Bundamedik Tbk is far larger — about 3.1× Saraswanti Indoland Development Tbk.'s market cap, and Saraswanti Indoland Development Tbk. is more actively traded (960.5K versus 536.7K). Which is the better fit depends on your goals.
| BMHS | SWID | |
|---|---|---|
Market Cap | 1.51T | 490.04B |
Volume | 536.7K | 960.5K |
Lot | 5.37K | 9.61K |
Turnover | 93.41M | 87.63M |
Average Price | 174.05 | 91.23 |
Value | 93.41M | 87.63M |
Indicative Equilibrium Price | 176 | 93 |
Indicative Equilibrium Volume | 100 | 12 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.
Read more on SWID →